This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Dianthus Therapeutics (DNTH)

Tipranks - Tipranks - Tue Jun 16, 7:44AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Jazz Pharmaceuticals (JAZZ) and Dianthus Therapeutics (DNTH) with bullish sentiments.

Claim 55% Off TipRanks

Jazz Pharmaceuticals (JAZZ)

Truist Financial analyst Gregory Renza maintained a Buy rating on Jazz Pharmaceuticals today. The company’s shares closed last Friday at $230.56.

According to TipRanks.com, Renza is a 5-star analyst with an average return of 15.1% and a 47.2% success rate. Renza covers the Healthcare sector, focusing on stocks such as Ascentage Pharma Group International Unsponsored ADR, Perspective Therapeutics, and Abivax SA Sponsored ADR. ;'>

Currently, the analyst consensus on Jazz Pharmaceuticals is a Strong Buy with an average price target of $262.77, an 11.6% upside from current levels. In a report issued on June 2, J.P. Morgan also maintained a Buy rating on the stock.

See today’s best-performing stocks on TipRanks >>

Dianthus Therapeutics (DNTH)

Truist Financial analyst Danielle Brill maintained a Buy rating on Dianthus Therapeutics today. The company’s shares closed last Friday at $82.07.

According to TipRanks.com, Brill is a 5-star analyst with an average return of 12.7% and a 54.0% success rate. Brill covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Rapport Therapeutics, Inc., and Praxis Precision Medicines. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Dianthus Therapeutics with a $130.63 average price target, representing a 68.7% upside. In a report issued on June 10, William Blair also maintained a Buy rating on the stock.

Read More on JAZZ:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).